chartexchange

GYRE
Gyre Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
4.34USD-4.715%(-0.22)466,629
After-hoursNov 18, 2026 4:26:30 PM EST
4.34USD-0.115%(-0.00)
Loading…
Loading…
477.21M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, California, USA
Previous Close
$4.56
Beta
1.58
52-Week High
$9.14 2026-03-05
52-Week Low
$3.97 2026-11-05
SMA 50
$6.15
SMA 200
$6.76
Avg. Vol 10D
283,762
Avg. Vol 30D
203,343
Avg. Vol 90D
139,848
Relative Vol
2.29
109.45M
32.26M
0.9700%
2,300,000
890
GYRE Profile

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

GYRE Performance
PeriodPriceDateChangeBeta
1W4.302026-11-12+1.40%-3.020
1M6.092026-10-19-28.41%2.376
3M7.152026-08-19-39.02%2.163
6M6.262026-05-19-30.35%1.473
1Y7.572025-11-19-42.40%1.582
2Y12.922024-11-19-66.25%—
5Y6.292023-11-01-30.68%1.578
GYRE Stock Summary

Gyre Therapeutics, Inc. Common Stock (NASDAQ:GYRE) stock price today is $4.36, and today's volume is 466,629. GYRE is down 4.386% today. The 30 day average volume is 203,343. GYRE market cap is $477.21M with 109.45M shares outstanding.